Advertisement
Screener

Anika Therapeutics, Inc. (ANIK) EBITDA

Anika Therapeutics, Inc. (ANIK) EBITDA

  • 2026-06-30: Basis Reported; EBITDA (m); Operating income $2.95M; Depreciation and amortization (m).
  • 2026-03-31: Basis Reported; EBITDA (m); Operating income -$5.49M; Depreciation and amortization (m).
  • 2025-09-30: Basis Reported; EBITDA (m); Operating income -$3.23M; Depreciation and amortization (m).
  • 2025-06-30: Basis Reported; EBITDA (m); Operating income -$4.18M; Depreciation and amortization (m).

Complete source-backed ebitda history.

Available history
2009-12-31 to 2013-03-31
Data captured

Historical EBITDA

EBITDA 3 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2026-06-30Reported(m)$2.95M(m)$32.61M(m)$1.45M*-$684.00K*$11.37M$7.34M$10.95M$71.00K
2026-03-31Reported(m)-$5.49M(m)$29.61M(m)$1.43M-$4.85M$10.62M$6.71M$17.77M$235.00K
2025-09-30Reported(m)-$3.23M(m)$27.82M(m)$1.89M*$6.87M*$12.23M$6.95M$11.87M$939.00K
2025-06-30Reported(m)-$4.18M(m)$28.22M(m)$1.47M*-$189.00K*$13.86M$6.31M$12.23M$681.00K
2025-03-31Reported(m)-$4.28M(m)$26.17M(m)$2.82M-$130.00K$11.49M$6.06M$12.91M$89.00K
2024-09-30Reported(m)-$81.00K(m)$29.56M(m)$1.22M*$5.02M*$10.15M$5.95M$13.54M$2.17M
2024-06-30Reported(m)-$1.81M(m)$30.72M(m)$3.40M*-$1.07M*$10.23M$6.68M$15.62M$1.33M
2024-03-31Reported(m)-$2.50M(m)$29.02M(m)$1.81M-$126.00K$10.05M$6.41M$15.07M$43.00K
2023-09-30Reported(m)-$7.67M(m)$41.47M(m)$741.00K*$6.49M*$16.52M$7.79M$24.83M-$463.00K
2023-06-30Reported(m)-$3.63M(m)$44.30M(m)$1.46M*-$8.29M*$15.33M$8.91M$23.69M-$329.00K
2023-03-31Reported(m)-$12.55M(m)$37.92M(m)$1.39M-$3.62M$15.08M$8.40M$27.00M-$1.66M
2022-09-30Reported(m)-$5.80M(m)$40.26M(m)$1.69M*$2.71M*$17.48M$7.30M$21.28M-$1.19M
2022-06-30Reported(m)-$3.38M(m)$39.66M(m)$1.94M*$3.09M*$14.79M$6.97M$21.27M-$442.00K
2022-03-31Reported(m)-$3.55M(m)$36.69M(m)$1.33M-$1.87M$14.89M$6.16M$19.20M-$775.00K
2021-09-30Reported(m)$1.30M(m)$39.54M(m)$1.28M*$2.06M*$16.51M$7.67M$17.50M$694.00K
2021-06-30Reported(m)$9.18M(m)$38.15M(m)$2.31M*$4.29M*$17.33M$7.29M$17.99M$2.60M
2021-03-31Reported(m)$1.26M(m)$34.29M(m)$417.00K-$2.43M$13.32M$6.36M$18.18M-$1.62M
2020-09-30Reported(m)-$7.93M(m)$31.69M(m)$271.00K*$5.87M*$14.35M$5.22M$15.90M-$1.74M
2020-06-30Reported(m)-$9.54M(m)$30.68M(m)$185.00K*$3.57M*$16.94M$4.53M$14.55M-$2.00M
2020-03-31Reported(m)$7.09M(m)$35.40M(m)$723.00K$1.04M$14.20M$6.05M$14.43M$1.58M
2019-09-30Reported(m)$12.05M(m)$29.70M(m)$428.00K*$10.05M*$5.95M$4.16M$7.54M$3.33M
2019-06-30Reported(m)$11.91M(m)$30.42M(m)$1.10M*$5.47M*$6.84M$4.17M$7.50M$3.01M
2019-03-31Reported(m)$5.48M(m)$24.72M(m)$1.03M$8.46M$7.31M$4.26M$7.67M$1.47M
2018-09-30Reported(m)$8.57M(m)$26.79M(m)$1.21M*$10.84M*$8.28M$4.23M$5.70M$1.50M
2018-06-30Reported(m)$11.25M(m)$30.55M(m)$740.00K*$4.47M*$8.15M$4.73M$6.42M$1.44M
2018-03-31Reported(m)-$7.83M(m)$21.26M(m)$2.54M$9.59M$7.84M$5.16M$16.09M-$1.05M
2017-09-30Reported(m)$10.27M(m)$27.18M(m)$2.59M*$12.10M*$6.25M$5.84M$4.82M$3.64M
2017-06-30Reported(m)$17.73M(m)$33.46M(m)$2.24M*$6.27M*$6.32M$4.45M$4.97M$6.37M
2017-03-31Reported(m)$8.01M(m)$23.39M(m)$1.68M$15.46M$6.08M$4.23M$5.07M$2.57M
2016-09-30Reported(m)$13.69M(m)(m)(m)$2.74M*$11.73M*(m)$2.82M$4.28M$4.83M
2016-06-30Reported(m)$13.47M(m)(m)(m)$3.45M*-$1.40M*(m)$2.79M$4.25M$4.90M
2016-03-31Reported(m)$10.71M(m)(m)(m)$6.42M$8.04M(m)$2.16M$3.99M$3.89M
2015-09-30Reported(m)$13.13M(m)(m)(m)$894.00K*$8.91M*(m)$2.06M$3.31M$4.79M
2015-06-30Reported(m)$12.43M(m)(m)(m)$878.00K*$10.90M*(m)$1.81M$3.39M$4.63M
2015-03-31Reported(m)$5.50M(m)(m)(m)$256.00K$3.98M(m)$2.10M$3.60M$2.01M
2014-09-30Reported(m)$10.29M(m)(m)(m)$242.77K*$7.39M*(m)$2.00M$4.04M$4.13M
2014-06-30Reported(m)$15.20M(m)(m)(m)$400.85K*$4.24M*(m)$1.87M$3.87M$5.91M
2014-03-31Reported(m)$23.87M(m)(m)(m)$276.51K$13.60M(m)$2.29M$3.49M$8.84M
2013-09-30Reported(m)$7.77M(m)(m)(m)$125.93K*$7.53M*(m)$1.62M$3.19M$2.78M
2013-06-30Reported$10.47M*$9.40M$1.07M*(m)(m)$74.07K*$3.56M*(m)$1.83M$3.40M$3.47M
2013-03-31Reported$6.21M(m)(m)(m)40.75%$35.80K$6.07M(m)$1.58M$3.95M$1.90M
2012-12-31Reported$8.95M(m)(m)(m)39.60%(m)(m)(m)(m)(m)(m)
2012-09-30Reported$3.91M*$2.73M$1.18M*(m)(m)$146.99K*$2.20M*(m)$1.22M$3.60M$1.04M
2012-06-30Reported$7.33M*$6.13M$1.20M*(m)(m)$921.43K*$5.22M*(m)$1.30M$4.11M$2.35M
2012-03-31Reported$4.05M(m)(m)(m)28.20%$224.06K-$1.69M(m)$1.53M$3.35M$1.10M
2011-12-31Reported$5.97M(m)(m)(m)32.39%(m)(m)(m)(m)(m)(m)
2011-09-30Reported$5.82M*$4.82M$1.00M*(m)(m)$298.17K*$2.98M*(m)$1.53M$4.71M$1.79M
2011-06-30Reported$4.70M*$3.68M$1.02M*(m)(m)$579.21K*-$1.40M*(m)$1.57M$4.23M$1.35M
2011-03-31Reported$1.48M(m)(m)(m)12.58%$76.57K$1.29M(m)$1.53M$4.04M$191.35K
2010-12-31Reported$3.34M(m)(m)(m)22.71%(m)(m)(m)(m)(m)(m)
2010-09-30Reported$2.87M*$2.08M$794.87K*(m)(m)$805.42K*$3.31M*(m)$1.77M$3.91M$853.49K
2010-06-30Reported(m)$1.80M(m)(m)(m)(m)(m)(m)$1.84M$4.97M$678.01K

EBITDA 12 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2025-12-31Reported(m)-$11.05M(m)$112.82M(m)$6.83M$11.19M$49.01M$25.77M$49.09M$672.00K
2024-12-31Reported(m)-$5.10M(m)$119.91M(m)$7.73M$5.40M$43.91M$25.54M$55.55M$6.06M
2023-12-31Reported(m)$844.00K(m)$120.79M(m)$5.43M-$1.79M$38.26M$21.76M$59.92M$6.59M
2022-12-31Reported(m)$3.67M(m)$113.83M(m)$7.49M$4.41M$40.61M$18.32M$51.23M$2.12M
2021-12-31Reported(m)$2.62M(m)$147.79M(m)$5.14M$8.40M$64.85M$27.33M$74.10M-$1.71M
2020-12-31Reported(m)-$28.32M(m)$130.46M(m)$1.63M$13.06M$61.43M$23.43M$60.06M-$4.64M
2019-12-31Reported(m)$34.25M(m)$114.61M(m)$2.83M$37.01M$28.75M$16.66M$34.95M$8.93M
2018-12-31Reported(m)$21.75M(m)$105.56M(m)$4.66M$34.92M$31.28M$18.19M$34.34M$4.49M
2017-12-31Reported(m)$45.73M(m)$113.42M(m)$8.98M$40.81M$27.36M$18.79M$21.54M$14.39M
2016-12-31Reported(m)$50.61M(m)$103.38M(m)$14.01M$24.45M$24.03M$10.73M$18.01M$18.32M
2015-12-31Reported(m)$48.13M(m)(m)(m)$9.22M$39.91M(m)$8.99M$14.82M$17.50M
2014-12-31Reported(m)$61.45M(m)(m)(m)$1.55M$39.98M(m)$8.14M$15.07M$23.19M
2013-12-31Reported(m)$32.61M(m)(m)(m)$441.00K$25.16M(m)$7.06M$12.94M$11.90M
2012-12-31Reported$24.24M(m)(m)(m)33.97%$1.50M$10.55M(m)$5.39M$14.73M$7.77M
2011-12-31Reported$17.97M(m)(m)(m)27.74%$1.40M$10.17M(m)$6.17M$17.86M$5.32M
2010-12-31Reported$10.86M(m)(m)(m)19.54%$2.78M$7.85M(m)$6.87M$17.32M$3.03M
2009-12-31Reported$6.88M(m)(m)(m)17.14%$3.96M$3.09M(m)$8.18M$10.55M$1.82M

Similar stocks

Stock NameCountryMarket CapPE Ratio
ORASURE TECHNOLOGIES INC (OSUR)United States$0.272B-6.26
Cytosorbents Corp (CTSO)United States$0.274B-1.29
TriSalus Life Sciences, Inc. (TLSI)United States$0.283B-9.92
InfuSystem Holdings, Inc (INFU)United States$0.253B22.52
Mobia Medical, Inc. (MOBI)United States$0.293B
TREACE MEDICAL CONCEPTS, INC. (TMCI)United States$0.297B-4.32
UTAH MEDICAL PRODUCTS INC (UTMD)United States$0.238B20.93
PRO DEX INC (PDEX)United States$0.234B13.64
Embecta Corp. (EMBC)United States$0.319B2.10
Neuronetics, Inc. (STIM)United States$0.216B-3.25